Terifrac Injection (3ml Each)
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Teriparatide (750mcg)
Overview Terifrac Injection (3ml Each)
Parathyroid hormone therapy, specifically Terifrac Injection (3ml vials), is a synthetic treatment for severe osteoporosis in men and postmenopausal women at heightened fracture risk. This medication promotes bone growth, thereby increasing bone mineral density and reducing vertebral fracture probability. Administered subcutaneously or by a medical professional, Terifrac requires consistent daily self-injection for optimal efficacy. Treatment typically lasts up to two years, though adherence to the prescribed regimen, even with symptom improvement, is crucial. Refrigerate between 2°C and 8°C. Common adverse effects include arthralgia, localized injection site reactions (pain, edema, erythema), and lower extremity muscle spasms. Consult your physician regarding persistent or troublesome side effects. Prior to commencing therapy, disclose any renal calculi or kidney disease history to your doctor, as hypercalcemia may occur. Pregnant or lactating individuals should seek medical guidance before using Terifrac. Your physician might recommend bone density monitoring to assess treatment response.
Primary Ingredients of Terifrac Injection (3ml Each)
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Terifrac Injection (3ml Each)
Brittle bone disease
Major Benefits of Terifrac Injection (3ml Each):
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Terifrac Injection (3ml Each):
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Terifrac Injection (3ml Each):
The medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Terifrac Injection (3ml Each) works:
Each 3ml Terifrac Injection delivers a synthetic version of the naturally occurring parathyroid hormone (PTH). Its mechanism involves stimulating osteoblast proliferation and activity, leading to enhanced bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Terifrac Injection (3ml Each) concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Terifrac Injection (3ml vials) during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Terifrac Injection (3ml vials) with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administering Terifrac Injection (3ml vials) can induce drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Terifrac Injection (3ml Each) cautiously, potentially requiring dosage modification. Consult a physician before use. Terifrac Injection (3ml Each) is contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Terifrac Injection (3ml vials) in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Terifrac Injection (3ml Each) :
Should you forget a dose of Terifrac Injection (3ml vial), administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Terifrac Injection (3ml Each)
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-Related Peptides |
| Developing Habits | No. |
| Type of Treatment | Endocrine Signals |



